CN110177541A - For preventing the external member and cosmetic system of skin aging - Google Patents
For preventing the external member and cosmetic system of skin aging Download PDFInfo
- Publication number
- CN110177541A CN110177541A CN201880005071.7A CN201880005071A CN110177541A CN 110177541 A CN110177541 A CN 110177541A CN 201880005071 A CN201880005071 A CN 201880005071A CN 110177541 A CN110177541 A CN 110177541A
- Authority
- CN
- China
- Prior art keywords
- skin
- laser
- composition
- treatment
- external member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/02—Furniture or other equipment specially adapted for hairdressers' rooms and not covered elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Biophysics (AREA)
- Cosmetics (AREA)
Abstract
For preventing the external member and cosmetic system of skin aging, it includes telomerase activating composition, dermis of skin irradiation laser, the composition and skin muscular sarcocyte irradiation laser for local fat removal comprising hyaluronidase, and the method for preventing human skin aging using the external member and system.The external member and cosmetic system for preventing skin aging is with resultant effect related with skin aging, although including instantaneous wrinkle improvement, skin repair, elasticity enhancing, wrinkle improvement, local fat removal and skin hydration improvement and the treatment time short lasting holding effect for being up to 1 year to 1.5 years.
Description
Technical field
The present invention relates to for preventing the external member and cosmetic system of skin aging comprising telomerase activating composition, skin
Skin corium irradiates laser, swashing for the composition of local fat removal and the irradiation of skin muscular sarcocyte comprising hyaluronidase
Light device, and the beauty method for preventing human skin aging using the external member and system.
Background technique
Human skin is passed at any time and is constantly changed, and the representative of this variation is the skin as caused by aging
Function deteriorates and aesthetics deteriorates.Other than internal abiogenous aging, various environmental factors can also cause aging.Skin aging
It is generally divided into Extrinsic aging caused by intrinsic aging as caused by inherent cause and external environmental factor as such as sunlight.
Exogen skin aging leads to the formation of wrinkle on skin.The typical factor for causing wrinkle includes fat accumulation, skin
Lower muscle loss, active oxygen, ultraviolet light, collagenous biological synthesis reduction etc..That is, external physical or chemical factor, for example, it is high temperature, strong
Ultraviolet light, physical abrasion (damage), acidic materials etc. cause the destruction of skin histology, this causes following collagen or bullet again
The destruction of property protein structure, gelatin etc., leads to the formation of wrinkle.
Specifically, collagen is generated and is found in main in extracellular matrix by the fibroblast in skin
Stromatin is the triple-helix structure for accounting for 30% important albumen of whole body protein by weight, and having firm.It is reported that glue
Former major function include keep the compact degree of the machinery of skin, the cohesive force of connective tissue and resistance, the adhesion strength that keeps cell,
It divides and breaks up with inducing cell.Known collagen and cumulative exposure are proportionally degraded in the time of ultraviolet light.Therefore, all
The denaturation for leading to the collagenous fibres in the accumulation and dermis of skin of elastic material such as the external factor of ultraviolet light causes to wrinkle in skin
The formation of line and the reduction of elasticity.
Although being difficult to adjust endogenous skin aging by manual method, the exogen skin compared with endogenous skin aging
Skin aging is easier to control, such as removal active oxygen, proliferation fibroblast and stimulation collagenous biological synthesis etc..With to wrinkle
The research for preventing and treat of line growth, the critical function of collagen is constantly identified in skin.Studies have shown that when passing through thorn
Swash the collagen in skin to generate come when increasing collagenic supersession, dermal matrix ingredient increases, causes wrinkle to improve, elasticity enhancing, skin
The compact equal such effect of skin.Emerging evaluation of wrinkle treatment include ultrasonic therapy, skin descale, laser lift-off, meat poisoning bar
Verticillium toxin injection etc..However, they are still unsatisfactory with regard to therapeutic effect and for the duration.
The endogenous skin aging of genetic determination may due to chromosome damage or Skin Cell loss and occur.Especially
Ground, due to fissional DNA replication dna mechanism, the telomere of end of chromosome plays the hereditary information that buffering shortens form in DNA
Loss effect.As every wheel cells divide, chromosome loses the DNA of certain length.It is being more than a certain number of cells point
After splitting, telomere becomes too short, eventually leads to cell division termination, subsequent cell death.On the other hand, it was reported that if telomere
Remain it is long, then cell have the extended service life, this can be completed by Telomerase.Therefore, to Telomerase as anti-
Only the strategy of the hereditary aging of cell is studied.
The prior art
Patent document
(patent document 1) 10-2014-0146074 South Korea patent application (on December 24th, 2014).
Summary of the invention
Technical problem
Present invention seek to address that the above problem.The external member that the object of the present invention is to provide a kind of for preventing skin aging and
Cosmetic system is formed using stimulation collagen, stimulates telomerase activation, restored the loss of elasticity due to caused by skin aging, change
Kind wrinkle, degrade undesired fat deposit and maintenance skin, and for preventing human skin using the external member and system
The beauty method of aging can prevent or delay exogen skin aging and endogenous for preventing skin aging comprehensively
Skin aging.The object of the invention is also to provide a kind of with shorter treatment time, the few intercurrent disease after treatment, instantaneous to wrinkle
Line improves and the external member and cosmetic system for being used to prevent skin aging of skin repair effect and lasting therapeutic effect, and
The beauty method of human skin aging is prevented for using the external member and system.
The present inventor is dedicated to developing a kind of for stimulating telomerase activation, restoring due to skin using stimulating collagen to be formed
Loss of elasticity caused by skin aging improves wrinkle, and degrade undesired fat deposit and maintenance skin are prevent skin aging
System, and it has been found that of the invention includes telomerase activating composition, dermis of skin irradiation laser, comprising hyaluronidase
For local fat removal composition and skin muscular sarcocyte irradiation laser for preventing the external member and beauty of skin aging
Appearance system, which has, can prevent or delay exogen skin aging and the comprehensive of endogenous skin aging to prevent skin aging
Effect.
The present invention includes composition and the light source (laser) with certain frequency, by it is comprehensive prevent due to it is hereditary because
Endogenous skin aging caused by element and the exogen skin aging due to caused by various factors and the skin recovery work for making aging
Power prevents skin aging.
In the present invention, preventing skin aging includes that stimulation collagen generates, and induces collagen contraction and collagen remodeling, maintenance by
In follow the string and caused by fat accumulation relaxation skin, enhancing skin elasticity and improve wrinkle.Prevent the skin aging from further including
The local fat of undesired accumulation is removed or reduced by making the telomerase activating in Skin Cell, in the cell that reduces fat
Fat, reduce oedema, prevent or delay endogenous skin aging.Prevent skin aging further include by improve pigmentation come
Improve skin hydration, improve skin roughness and improves the colour of skin.That is, preventing skin aging from referring in the present invention, but it is not limited to,
Improve or prevent one or more skin aging symptoms listed above.
Solution
Hereinafter, will be explained in detail according to the present invention includes A) telomerase activating composition, B) dermis of skin irradiation
Laser, C) composition and D for local fat removal) skin muscular sarcocyte irradiation laser for preventing skin aging
External member and cosmetic system and use its treatment method.
※ telomerase activating composition (A)
As used herein, term " Telomerase " refers to the enzyme for keeping telomere length, and the inhereditary material is by seeing chromosome end
The repeated nucleotide sequences at end are constituted, for preventing cell ageing.Telomere protects chromosome to contaminate from damage or with other
Colour solid fusion, and their length shortens as every wheel cells divide.It is being more than telomere change after a certain number of cell divisions
Must be too short, cause cell division to terminate, subsequent cell death.
Therefore, Telomerase is for keeping cell to be in pre- by preventing the loss of cellular genetic material and hereditary information
The enzyme of ageing phase.In the present invention, cell ageing, the telomerase activating group are prevented by using telomerase activating composition
It closes object activation Telomerase (expression for increasing telomere albumen) and keeps telomere length long.
In the present invention, any composition that can activate Telomerase can be used as telomerase activating composition.This hair
Bright telomerase activating composition is characterized in that it increases the table of the subunit protein of Skin Cell middle-end corpuscular protein complex
Reach and/or keep the telomere length of chromosome in Skin Cell.
In the present invention, the subunit protein of telomere protein complexes is selected from TRF1 (telomere repetition factor 1), (end TRF2
Grain repetition factor 2), RAP1 (suppressing Activating protein-1), TIN2 (TERF1- interact nuclear factor 2), (telomere protects egg to POT1
It is white 1) and one of TPP1 (three peptidyl peptidases 1) or a variety of.
In one embodiment, telomerase activating composition of the invention includes Dendropanax morbifera
Lev. extract, Kappaphycus alvarezii extract or their mixture are as active constituent.Of the invention
Dendropanax morbifera Lev. extract or Kappaphycus alvarezii extract can pass through grinding
Dendropanax morbifera Lev. bark or Kappaphycus alvarezii, then in solvent (water, C1To C6Alcohol or
Organic solvent such as ethyl alcohol, methanol, hexane etc.) in precipitate and with hydrolysis enzymatic treatment with obtain extract prepare, but not limited to this.
In the present invention, telomerase activating composition can be with 0.00001 to 10% (w/w), 0.0001 to 5% (w/w)
Or 0.001 to 3% (w/w) amount contain active constituent Dendropanax morbifera Lev. extract or
Kappaphycus alvarezii extract.
In the present invention, telomerase activating composition can be used conventional carrier, diluent or excipient such as lubricant, moisten
Agent, flavoring agent, emulsifier, suspending agent, preservative, surfactant etc. are prepared.In one embodiment, telomerase activating group
Closing object is topical preparation.Specifically, can be formulated as essence, therapeutic agent, serum, lotion, creme, ampoule, lotion or
Packaging, but not limited to this.According to its formula, in addition to active constituent Dendropanax morbifera Lev. extract or
Except Kappaphycus alvarezii extract, above-mentioned composition also may include commonly used in each formula antioxidant,
Stabilizer, solubilizer, vitamin, pigment, fragrance etc..
The example of the carrier, diluent and excipient includes but is not limited to lactose, dextrose, sucrose, D-sorbite, sweet
Reveal alcohol, starch, gum arabic, alginate, gelatin, calcium silicates, polyvinylpyrrolidone, cellulose, water, syrup, hydroxyl
Yl benzoic acid methyl esters, nipasol, xanthan gum, talcum powder, magnesium stearate, mineral oil etc..
In another embodiment, telomerase activating composition of the invention is cosmetic composition, and can be into
One step includes the well-known substance to skin with useful effect in field of cosmetics composition.For example, can also comprise
Herba Visci extract, cogongrass rhizome extractive, extract of soybean etc..Each extract of the invention can be through microorganism such as ferment
Female or lactobacillus fermentation extract, but not limited to this.
As the preparation embodiment of telomerase activating composition of the invention, preparation contains 0.00056% (w/w's)
The ampoule and creme (Tables 1 and 2) of Kappaphycus alvarezii extract.
The amount of telomerase activating composition of the invention to be administered in skin according to skin, composition formula,
The variation such as administration time, but can suitably be selected by those skilled in the art.Specifically, the composition of single dose is 3 to 20cc, and
And the composition can be applied 1 to 5 time daily as needed.
In the present invention, the application of telomerase activating composition can be with the ultrasonic laser for being 10 to 90Hz with frequency
Treatment.Here, adjoint treatment refers to application telomerase activating composition simultaneously or after applying telomerase activating composition
It is treated immediately with ultrasonic laser, irradiation continues 5 to 20 minutes.In one embodiment of the invention, inciting somebody to action
After 10cc telomerase activating composition is applied to skin, irradiation frequency is ultrasonic laser 10 minutes of 30Hz.
※ dermis of skin irradiates laser (B)
Dermis of skin irradiation laser of the invention is the laser or RF (radio frequency) laser that frequency is 2 to 100Hz, and
And it transfers thermal energy to corium or is transferred to corium and SMAS (superficial muscular aponeurotic system).Dermis of skin irradiation of the invention swashs
Light device can be one or more lasers.For example, it is selected from, [laser that frequency is 2 to 9Hz], [frequency is 30 to 50Hz
Laser] and [RF (35MHz to 45MHz) laser] one or more.
The dermis of skin irradiation laser that for wavelength of the invention be 1064nm and frequency is 2 to 9Hz gos deep into corium simultaneously
Transferring heat energy, so that collagen be stimulated to generate.Irradiation time may be, but not limited to, and 1 to 10 minute.
The dermis of skin that frequency used in the present invention is 30 to 50Hz irradiates laser and uses high intensity focused ultrasound
(HIFU) laser energy (65 DEG C of thermal energy) is transferred to deep dermis and SMAS.This causes the contraction of subepidermal muscle layer,
Cause wrinkle to reduce, and facilitates the generation of collagen and elastin laminin.It is meanwhile if there is excess fat layer, then this
Laser facilitates lipolysis.The laser can be operated according to the depth that laser wave reaches with two different modes.One
In kind mode, laser wave reaches 3.5mm depth under the surface of the skin and shrinks skin corium, to reduce wrinkle and stimulation collagen
It is generated with elastin laminin.In another mode, laser wave reaches 4.5mm depth under the surface of the skin, facilitates fatty in skin
The lipolysis of layer.Treatment may include both any one of above two mode or both of which.Irradiation time can divide
Wei not be 10 to 40 minutes, but not limited to this.
92W used in the present invention RF laser (35MHz to 45MHz) allow RF wave penetrate dermis of skin/fat deposit,
Heat is generated in deep dermis and to which induced tissue is shunk and is recombinated.When laser generates heat in connective tissue, blood stream
Dynamic and circulation increases, and causes tissue compact and improved dermatoglyph.The effect of this laser also resides in iuntercellular water and nocuousness
Substance is discharged, and contoured skin in irradiation area is caused significantly to be tightened.The laser can irradiate 3 to 10 under monopolar mode
Minute, but not limited to this.
The laser of the invention that energy is transmitted to deep dermis can be selected from the laser of above-mentioned three types.It
It can be any combination selected from the laser of above-mentioned three types, or swashing for all three types can be used together
Light device.
It is 1064nm by wavelength in the of the invention specific embodiment using dermis of skin irradiation laser treatment
And frequency is the laser illumination 3 of 5Hz (GentleMax) or 5 minutes, then (laser wave reaches A under the surface of the skin in mode
3.5mm is deep) and Mode B (laser wave reaches 4.5mm depth under the surface of the skin) the indigo laser that irradiation frequency is 30 to 50Hz, divide
Do not continue 10 or 20 minutes.Finally, frequency of use is RF laser illumination skin 6 minutes of 40.68MHz.
By to corium or to corium and SMAS transferring heat energy, dermis of skin irradiation laser of the invention can bring with
One of lower variation is a variety of:
I) contraction and recombination of dermal tissue;
Ii) the contraction of skin muscular sarcocyte;
Iii) the generation of inducing collagen, elastin laminin or collagen and elastin laminin;
Iv) increase the blood flow and Lymphatic Circulation in skin connective tissue;With
V) water and harmful substance present in skin is discharged.
※ is used for the composition (C) of local fat removal
The composition for local fat removal of every single dose volume of the invention includes the transparent of 300IU to 600IU
Matter acid enzyme, and local anesthetic, antihistaminic, lipolysis stimulant and collagen can be further included and generated in stimulant
It is one or more.
Hyaluronidase is the water-soluble enzyme from mammal vas deferens or testicular secretion, it is characterised in that it passes through hydrolysis
Glucose amine key between a kind of main cytoplasm of hyaluronic acid-and connective tissue is to dissolve the screen between key removal tissue
Barrier and the effect for reducing the proliferation of fibrous tissue in tissue.It it is known that hyaluronidase reduces the swelling and oedema in tissue.
Using the characteristic of the substance in hyaluronic acid enzyme hydrolysis and dissolution skin histology, LLD (lipolysis leaching is widely used
Ba Yinliu) to treat, wherein hyaluronidase is directly subcutaneously injected with the substance including the fiber in subcutaneous tissue of degrading, thus
It is fat to reduce adipose tissue and mitigation to help to drain adipose tissue to promote Lymphatic Circulation.However, although above-mentioned treatment helps
In reduction adipose tissue, but due to the hyaluronidase that it uses high dose (2000 to 15000IU), with various side effects
It is related.
Cause allergic symptom, such as rubescent or itch, and fat using the existing LLD treatment of high dose hyaluronidase
The excessive dissolution of tissue causes due to subcutaneous hemorrhage or bruise caused by being recessed.LLD treatment has the disadvantages that treatment is had to
It frequently interrupts to handle these side effects, and repels because patient is due to pain, therefore, it is difficult to continuously be treated.
In addition, making it difficult to reduce the interval (interval about 5cm) between injection point using the hyaluronidase of high dose.Cause
This, fat removal is focusing only on around injection point, causes the scrambling and skin of such as impression, relaxation and wrinkle of skin
The significant decrease of elasticity, and therefore lead to being discontented with for patient.
After making great efforts to solve the above problems, the inventors discovered that, show that the minimum hyaluronic acid enzyme amount of effect is 300IU,
And it was found that being higher than 600IU, fat cell is excessively hydrolyzed, and causes the concern to recess or subcutaneous hemorrhage.Therefore, by incite somebody to action this
Hyaluronidase in the injectable composition for local fat removal of the single dose of invention is adjusted to 300IU to 600IU,
Make by using the drug bring side effect to minimize, and the smallest volume can be used, fat is carried out to extensive region
It removes.
In clinical test it has been shown that under the hyaluronidase activity of 300IU and the volume injected of 1cc, injection group
The diameter for closing the range of scatter of object is about 1cm.Therefore, it is combined by being injected between 0.5 to 2cm injection point with narrow interval
Object can promote uniform fat removal and be generated by the collagen of skin irritatin.
Most preferably, injectable composition of the invention is injected, is infused every time with giving the hyaluronidase of 300IU to 600IU
Penetrate, single dose volume is 0.5 to 2cc, between injection point between be divided into 0.5 to 1.5cm.The daily dose of hyaluronidase is preferably
15,000IU or lower, and single dose volume and injection point can suitably be adjusted according to the IU of hyaluronidase.
Injectable composition of the invention can the 1cc volume injected based on the hyaluronidase containing 300IU between fixation
Every injection 50 times, and injection site can be the fatty heap including abdomen, buttocks, thigh, shank, chin, forehead, arm etc.
Long-pending any body region.
Injectable composition of the invention can also comprising local anesthetic with mitigate inject caused by pain, antihistaminic with
Prevent anaphylaxis side effect, lipolysis stimulant fatty acid into mitochondria and to be degraded from the fatty rapid transport of degradation
They and collagen stimulation agent.Therefore, injectable composition prevents allergic symptom for example rubescent or itch and pain and bruise, adds
Fast fat removal, and excellently formed by collagen and keep skin elasticity.
It about above-mentioned local anesthetic, can be counted on the basis of the total weight of composition, the injectable composition includes weight
It measures the amount that percentage is 0.08 to 0.4% and uses lidocaine.When the amount of local anesthetic is lower than 0.08%, analgesic activity is not
It is satisfactory, and when the amount is higher than 0.4%, the duration extension of anesthesia and be uneconomic.
About other compositions, with the amount that weight percent is 0.01 to 0.02% contain antihistaminic skin stretching-sensitive (English:
Peniramin, pheniramine), lipolysis stimulant L-carnitine is contained with the amount that weight percent is 0.01 to 4.0%,
And collagen is contained with the amount that weight percent is 0.1 to 2.0% and generates stimulant vitamin C.
Composition of the invention can also be in the dosage range that injectable composition allows comprising selected from molten commonly used in injecting
One or more substances of tonicity agents, nonionic surfactant, stabilizer, the preservative of liquid etc..Composition of the invention is also
The total amount that can be 0.01 to 4.0% with weight percent includes fat-splitting agent such as phosphatidyl choline, aminophylline, caffeine
Deng, and improve sanguimotor placental hormone component or pentoxifylline.
It is the case where for wherein giving the hyaluronidase of 300IU with the expectation daily dose of 15,000IU, respective at its
The amount of mentioned component in preparation is determined in maximum daily dose.
In an embodiment of the injectable composition for local fat removal of the invention, every single dose volume note
Penetrating composition includes that the hyaluronidase of 300IU to 600IU and base are counted on the basis of the total weight of injectable composition, the note
Penetrate composition also and include the lidocaine that weight percent is 0.08 to 0.4% is as local anesthetic, weight percent
0.01 to 0.02% skin stretching-sensitive is divided as antihistaminic, the L-carnitine that weight percent is 0.01 to 4.0% as fat
It solving the vitamin C that stimulant and weight percent are 0.1 to 2.0% and generates stimulant as collagen, remaining is salting liquid, and
And the composition is with the every single dose injection of 0.5 to 2cc volume, between injection point between be divided into 0.5 to 1.5cm.
In the specific preparation embodiment for the injectable composition for local fat removal of the invention, preparation includes
The hyaluronidase of 30,000IU to 60,000IU, the lidocaine of 210mg, the skin stretching-sensitive of 12mg, 660mg L-carnitine,
With the composition of the ascorbic 100cc of 600mg.
※ skin muscular sarcocyte irradiates laser (D)
Skin muscular sarcocyte of the invention irradiates laser inside mouth towards face irradiation, and be frequency is 1 to 3.5Hz
Laser, transfer its energy to skin muscular sarcocyte.Since this laser transfers its energy to muscle layer, it is to glue
It is primary improve at, wrinkle and elasticity enhancing have the effect of it is fabulous.In particular, by irradiating laser towards face inside mouth
Beam can effectively transfer its energy to skin muscular sarcocyte.
Specifically, which is painless, and with non-ablative, Noninvasive side in the case where no anesthesia
Formula provides fuel factor to oral mucosa, to provide remodeling and tightening effect.In the mouth of the step treatment use laser beam provide by
Energy is controlled, so that reaching the temperature of 45 to 70 DEG C or 45 to 65 DEG C ranges in dermis, this can lead to 30% wink of tissue
When shrink.Organized layer deeper below is pulled to the instantaneous contract of dermis, generates and promotes effect.
Since above-mentioned laser treatment transmits energy by oral mucosa, it can protect epidermis and stimulates collagen weight
Modeling and virgin rubber original shape are at (collagenesis) (lasting up to 6 months).In addition, this laser treatment has the following advantages that,
It is not accompanied by bleeding or pain other than some warming senses in oral mucosa, and it does not influence the daily life after treatment
It is living, because of the especially fast quick-recovery of oral mucosa.
In the of the invention specific embodiment using skin muscular sarcocyte irradiation laser treatment, from mouth inside direction
The skin muscular sarcocyte that facial irradiation frequency is 1.8Hz or 3Hz irradiates laser 5 or 6 minutes.
By transferring thermal energy to skin muscular sarcocyte or being transferred to skin muscular sarcocyte and dermis, skin muscular of the invention
Sarcocyte irradiation laser can bring one of following variation or a variety of:
I) collagen remodeling in skin muscular sarcocyte and virgin rubber original shape at;
Ii) the contraction of skin muscular sarcocyte;With
Iii) the tissue contracts of dermis.
Detailed embodiment of the invention explained below.
To achieve the purpose of the present invention, one aspect of the present invention provides a kind of for preventing the external member of skin aging, wraps
Containing A) telomerase activating composition;B) dermis of skin irradiates laser;C) the use of the hyaluronidase comprising 300IU to 600IU
In the composition of local fat removal;And D) skin muscular sarcocyte irradiation laser.
Moreover, according to the present invention for preventing the external member of skin aging from may further include frequency as 10 to 90Hz's
Ultrasonic laser is administered simultaneously with application telomerase activating composition, or is stood after using telomerase activating composition
Apply.
In external member of the invention, can not consider their sequence, for example, with the sequence, with reverse order or with
Machine sequence carry out using above-mentioned elements A) to D) treat.
For example, external member of the invention can by [A), B), C) and D)], [A), B), D) and C)], [A), C), B) and D)],
[A), C), D) and B)], [A), D), B) and C)], [A), D), C) and B)], [B), A), C) and D)], [B), A), D) and C)]
[B), C), A) and D)], [B), D), A) and C)], [B), D), C) and A)], [C), A), B) and D)], [C), A), D) and B)]
[C), B), A) and D)], [C), B), D) and A)], [C), D), A) and B)], [C), D), B) and A)], [D), A), B) and C)]
[D), A), C) and B)], [D), B), A) and C)], [D), B), C) and A)], [D), C), A) and B)], or [D), C), B) and A)]
Sequence use.
In addition, 1 to 10 circulation may be reused in external member of the invention, but not limited to this.It in each cycle, can be with
Use above-mentioned elements A) treated to D), but regardless of they sequence how.
On the other hand, the present invention provides a kind of for preventing the cosmetic system of skin aging, and it includes A) telomerase activating
Composition;B) dermis of skin irradiates laser;C) local fat that is used for of the hyaluronidase comprising 300IU to 600IU removes
Composition;And D) skin muscular sarcocyte irradiation laser.
Telomerase, telomerase activating composition, dermis of skin irradiation laser, hyaluronidase, comprising 300IU extremely
The hyaluronidase of 600IU irradiates laser for the composition of local fat removal and skin muscular sarcocyte of the invention
As described above.
Cosmetic system according to the present invention can also include the ultrasonic laser that frequency is 10 to 90Hz, with application telomere
Enzyme activation composition simultaneously or applied immediately after applying telomerase activating composition.
Cosmetic system of the invention includes following element.When using the cosmetic system, it can execute and use following element
Treatment but regardless of they sequence how, for example, with the sequence, with reverse order or with random sequence:
I) the telomerase activating composition to be administered in skin;
Ii) the dermis of skin irradiation laser to be illuminated for continuing 3 to 60 minutes on the skin;
Iii) the composition for local fat removal, waits for being injected with 0.5 to 2cc single dose volume, injects
0.5 is divided into 1.5cm between point;With
Iv) skin muscular sarcocyte irradiates laser, waits for inside mouth towards face irradiation 3 to 10 minutes.
It is stood simultaneously or after with element i) treatment in addition, cosmetic system of the invention may also include with element i) treatment is used
I.e. irradiation frequency is ultrasonic laser 5 to 20 minutes of 10 to 90Hz.
For example, cosmetic system of the invention can use in the following order: [i), ii), iii) and iv)], [i), ii),
Iv) and iii)], [i), iii), ii) and iv)], [i), iii), iv) and ii)], [i), iv), ii) and iii)], [i), iv),
Iii) and ii)], [ii), i), iii) and iv)], [ii), i), iv) and iii)], [ii), iii), i) and iv)], [ii),
Iv), i) and iii)], [ii), iv), iii) and i)], [iii), i), ii) and iv)], [iii), i), iv) and ii)], [iii),
Ii), i) and iv)], [iii), ii), iv) and i)], [iii), iv), i) and ii)], [iii), iv), ii) and i)], [iv),
I), ii) and iii)], [iv), i), iii) and ii)], [iv), ii), i) and iii)], [iv), ii), iii) and i)], [iv),
Iii), i) and ii)], or [iv), iii), ii) and i)].
In cosmetic system of the invention, above-mentioned ii) in dermis of skin irradiation laser be swashing for 5Hz selected from frequency
One or more lasers of light device, the laser that frequency is 30 to 50Hz and RF laser.The laser that can be 5Hz by frequency
Device irradiates 3 to 8 minutes, and by frequency is laser illumination 15 to 40 minutes of 30 to 50Hz.RF laser can be with
The frequency of 40.68MHz is irradiated 4 to 10 minutes.
In addition, cosmetic system of the invention can be reused in 1 to 10 circulation, but not limited to this.It is followed each
In ring, may be used the treatment of above-mentioned element i) to iv) but regardless of they sequence how.For example, using element i),
Ii), iii) and treatment iv) can be carried out with the sequence, be divided into one week, and whole process is considered as one and follows
Ring, treatment can repeat three circulations.
In of the invention one specific treatment embodiment, application contains the Kappaphycus of 0.00056% (w/w)
Then the telomerase activating composition of alvarezii extract is irradiated 10 minutes with the ultrasonic laser that frequency is 30Hz.It connects down
Come, as dermis of skin irradiate laser, frequency be 5Hz laser (GentleMax) irradiate 5 minutes, and in mode A and
Mode B irradiates the laser that a kind of frequency of indigo laser-is 30 to 50Hz, continues 20 minutes respectively, then frequency of use is
The RF laser illumination of 40.68MHz 6 minutes.Then, using the hyaluronic acid comprising 30,000IU to 60,000IU of 100cc
Enzyme, the lidocaine of 210mg, the skin stretching-sensitive of 12mg, the L-carnitine of 660mg and the ascorbic of 600mg are used for local fat
The composition of removal, each injection single dose volume 1cc at 50 points, between injection point between be divided into 1cm, between one week
Every injection four times.Hereafter, laser 5 is irradiated towards the skin muscular sarcocyte that facial irradiation frequency is 1.8Hz or 3Hz inside mouth to divide
Clock.
In another treatment embodiment of the invention, the Kappaphycus containing 0.00056% (w/w) of 3cc is applied
Then the telomerase activating composition of alvarezii extract is irradiated 10 minutes with the ultrasonic laser that frequency is 30Hz.It connects down
Come, as dermis of skin irradiate laser, frequency be 5Hz laser (GentleMax) irradiate 3 minutes, and in mode A and
Mode B irradiates the laser that a kind of frequency of indigo laser-is 30 to 50Hz, continues 10 minutes respectively, then with monopolar mode
It uses RF laser illumination 6 minutes of 90w.Then, the hyaluronic acid comprising 30,000IU to 60,000IU of 100cc is prepared
Enzyme, the lidocaine of 210mg, the skin stretching-sensitive of 12mg, the L-carnitine of 660mg and the ascorbic of 600mg are used for local fat
The composition of removal, and at 10 points each injection 1cc single dose volume, between injection point between be divided into 1cm.This
Afterwards, it is irradiated laser 6 minutes inside mouth towards the skin muscular sarcocyte that facial irradiation frequency is 3Hz.
On the other hand, the present invention provides according to the present invention for preventing the external member and beauty of skin aging for using
Appearance system prevents the beauty method of skin aging.
It is according to the present invention to be used to prevent the external member of skin aging and cosmetic system as described above.
Specifically, the present invention provides a kind of for preventing the beauty method of skin aging, wherein carries out following steps
Its sequence is considered at least once and not:
I) the step of applying telomerase activating composition;
Ii the step of) irradiation dermis of skin irradiates laser 3 to 60 minutes;
Iii) with 0.5 to 2cc single dose volume come inject for local fat removal composition the step of, injection point
Between between be divided into 0.5 to 1.5cm;With
Iv the step of) being irradiated laser 3 to 10 minutes inside mouth towards face irradiation skin muscular sarcocyte.
In addition, beauty method of the invention may also include, irradiation frequency is immediately simultaneously or after step i) with step i)
10 to 90Hz ultrasonic laser 5 to 20 minutes.
In the present invention, can execute above-mentioned steps but regardless of they sequence how, for example, with the sequence, with phase
Reverse-order or with random sequence.For example, above-mentioned steps can carry out in the following order: [i), ii), iii) and iv)], [i),
Ii), iv) and iii)], [i), iii), ii) and iv)], [i), iii), iv) and ii)], [i), iv), ii) and iii)], [i),
Iv), iii) and ii)], [ii), i), iii) and iv)], [ii), i), iv) and iii)], [ii), iii), i) and iv)],
[ii), iv), i) and iii)], [ii), iv), iii) and i)], [iii), i), ii) and iv)], [iii), i), iv) and ii)]
[iii), ii), i) and iv)], [iii), ii), iv) and i)], [iii), iv), i) and ii)], [iii), iv), ii) and i)]
[iv), i), ii) and iii)], [iv), i), iii) and ii)], [iv), ii), i) and iii)], [iv), ii), iii) and i)]
[iv), iii), i) and ii)], or [iv), iii), ii) and i)].
Above-mentioned steps i) to iv) can be carried out by the same person, and when can be arranged suitable between the steps
Between be spaced.Appropriate intervals between step can be 1 to 60 minute, 1 to 24 hour or 1 day to 2 weeks, this depends on skin
Situation and the time treated next time.Time interval can be determined by those skilled in the art, and can be according to treatment
Step and skin variation.
Step ii of the invention) in dermis of skin irradiation laser be selected from frequency be 5Hz laser, frequency 30
To the laser of 50Hz and one or more lasers of RF laser.It can be 3 to 8 points of laser illumination of 5Hz by frequency
Clock, and by frequency be laser illumination 15 to 40 minutes of 30 to 50Hz.RF laser can irradiate 4 with the frequency of 40.68MHz
To 10 minutes.
External member and cosmetic system according to the present invention for preventing skin aging has synthesis related with skin aging
Effect, including the improvement of instantaneous wrinkle, skin repair, elasticity enhancing, wrinkle improve, local fat removal and skin hydration improve with
Although and treatment time is short but is up to 1 year to 1.5 years lasting holding effect.Therefore, the present invention is in terms of preventing skin aging
Have the effect of excellent.
Detailed description of the invention
Fig. 1 is shown with H2O2After inducing aging, at 0.25% or 0.5%Kappaphycus alvarezii extract
The expression of fibroblast middle-end the corpuscular protein POT1 and TPP1 of reason.
Fig. 2 shows with H2O2After inducing aging, at 0.25% or 0.5%Kappaphycus alvarezii extract
Telomere length in the fibroblast of reason.
Fig. 3 is shown using beta galactosidase dyeing external member (Sigma Senescent cell dyeing external member) with H2O2
It uses after induction aging and is measured in the fibroblast of 0.25% or 0.5%Kappaphycus alvarezii extract-treated
Aging degree photo.
Fig. 4 shows the aging degree measured in clinical studies by Laser Scanning Confocal Microscope in beginning day and the 42nd day,
Effect is prevented to skin aging to verify the composition comprising Kappaphycus alvarezii extract.
Fig. 5, which is shown, is starting the aging degree measured by 3D scanner of day and the 42nd day in clinical studies, to test
Card prevents effect to skin aging comprising the composition of Kappaphycus alvarezii extract.
Fig. 6 is shown in clinical studies to measure the perception test at age for starting day and the 42nd day subject
As a result, preventing effect to skin aging to verify the composition comprising Kappaphycus alvarezii extract.
Fig. 7, which is shown in, irradiates after laser illumination the elasticity for enhancing double chin and cheek region immediately with dermis of skin
The photo of contoured skin.
Fig. 8 is the photo of the nasolabial groove wrinkle after irradiating laser treatment 1 time (session) with skin muscular sarcocyte.
Fig. 9 is grouped into test group for 1 week, 2 weeks, 3 weeks and 4 weeks after being shown in baseline and treatment and compares 90 in 1 to 8
The quantity of the collagenous fibres measured in the Skin biopsy of subject, with study comprehensively it is according to the present invention for preventing or
Treat the external member of skin aging and the effect of cosmetic system.Represent test group A of the invention) telomerase activating composition, B)
Dermis of skin irradiates laser, C) it is used for the composition and D of local fat removal) skin muscular sarcocyte irradiation laser treatment, and
Control group receives only some treatments in these treatments.Specifically, control 1 receives treatment A;Control 2 receives treatment B;It is right
Receive treatment C according to 3;Control 4 receives treatment D;Control 5 receives treatment A, B and C;Control 6 receives treatment A, B and D;Control 7 receives
Treat A, C and D;Control 8 receives treatment B, C and D.
Figure 10 shows the subject after baseline and treatment in 1 week, 2 weeks, 3 weeks and 4 weeks test group and control 1 to 8
The skin elasticity of middle measurement improves.Skin is assessed using DermaLab USB elastic probe (Cortex Technology, Inc.)
The variation of elasticity.
Figure 11 is shown through measurement test group and control 1 to 81 week, 2 weeks, 3 weeks and 4 weeks after baseline and treatment
The effect improving wrinkles that wrinkle in subject determines.Use device (the Aramo TS, by Aram HUVIS of quantization wrinkle degree
Co., South Korea, programming) assess the variation to corrugate.
Figure 12 show after baseline and treatment 1 week, 2 weeks, 3 weeks and 4 weeks it is tested in test group and control 1 to 8
The facial maintenance effect measured in person.Use the French sound section image (Les of the thickness of measurement facial area subcutaneous fat
Jardinsde la Duranne, Aix en Provence, France) ultrasonic wave assessed.
Figure 13 shows 1 week, 2 weeks, the 3 weeks and 4 weeks subject in test group and control 1 to 8 after baseline and treatment
The Activation of Telomerase effect of middle measurement.The blood sample from subject is analyzed by sandwich enzyme immune measuring method to measure telomere
The amount of enzyme.
When Figure 14 is shown 1 week, 2 weeks, 3 weeks and 4 weeks after baseline and treatment test group and control 1 to 8 in by
The skin hydration measured in examination person improves.Skin hydration is determined by the capacitor of measurement reflection water content, and the water content exists
There is highest dielectric constant in skin.
Figure 15 is shown through measurement test group and control 1 to 81 week, 2 weeks, 3 weeks and 4 weeks after baseline and treatment
The skin roughness that skin roughness in subject determines improves.Using diameter be 30mm Silver Mirror (beauty scope,
60 mirror of X) image of test zone is shot, and skin surface contours are converted into figure and number to obtain pachylosis angle value.
Figure 16 shows the subject after baseline and treatment in 1 week, 2 weeks, 3 weeks and 4 weeks test group and control 1 to 8
The variation of the pigmentation amount of middle measurement.RSA (Robo Skin Analyzer CS 50, In Forward.Inc., Japan)
Allow to be combined pore, pigmentation, wrinkle, colour of skin etc. inspection, and the instrument is used to measure the change of pigmentation amount
Change.
Invention mode
Illustrate how the present inventor studies to obtain the set for preventing skin aging below with reference to embodiment and embodiment
Part and cosmetic system, and the beauty side for preventing human skin aging using external member according to the present invention and system
Method.
Reference implementation example
Reference implementation example 1: preparing telomerase activating extract and verifies its effect
(1) telomerase activating extract is prepared
Telomerase activating composition is prepared using Kappaphycus alvarezii extract.Specifically, will
Kappaphycus alvarezii grinding, then in solvent (water, C1To C6Alcohol or organic solvent such as ethyl alcohol, methanol, hexane etc.)
Then hydrolase is added to obtain extract in middle precipitating.
(2) experiment in vitro of skin aging is prevented
Have studied Kappaphycus alvarezii extract prepared above prevents effect to skin aging in vitro.
When Telomerase is activated, the telomere length of end of chromosome is maintained or extends in cell, to extend the service life of cell.
In this respect, the aging of human fibroblasts (human fibroblast) is tested.
By human fibroblast cell line with 1800 cell/cm2Concentration be placed in 100-mm plate (Corning 100mm TC-
Treated Culture Dish, Product#430167) in, and use and contained with the ultimate density of 0.25% or 0.5%
The fibroblast culture medium of Kappaphycus alvarezii extract is handled.Then, by with H2O2(peroxidating
4 × 40 μM of hydrogen) 96 hours are handled to induce aging.Use pre- senescent fibroblast and as the use same procedure of control and
It is induced after aging but does not have to the fibroblast that Kappaphycus alvarezii extract is handled, comparative group middle-end
The length of grain and the expression of telomere albumen.
With POT1 and TPP1 in the test group of Kappaphycus alvarezii extract-treated (for protecting and keeping
The telomere albumen of telomere length) expression remain it is high.In particular, as the Kappaphycus for being 0.5% with concentration
When alvarezii extract-treated cell, the expression of above-mentioned albumen is maintained close to the level of normal pre- senescent fibroblast.
In contrast, Kappaphycus alvarezii extract is being not used by induction aging in the expression of above two albumen
It handles in the fibroblast of aging and is reduced to 68% and 82% (Fig. 1) respectively.
In addition, telomere shorten the result shows that, with concentration be 0.5% Kappaphycus alvarezii extract-treated
As caused by aging about 65% telomere can be inhibited to shorten (Fig. 2).
Finally, aging is induced in fibroblast under conditions of same as described above and is dyed using beta galactosidase
The aging degree of external member (Sigma senile cell dye external member) measurement the experimental results showed that, be 0.5% with concentration
Cell ageing degree significantly reduces (Fig. 3) in the cell of Kappaphycus alvarezii extract-treated.
(3) experiment in vivo of skin aging is prevented
The healthy volunteer that average age is 59 ± 5 is divided into the placebo of 21 subjects and the survey of 24 subjects
Examination group.For test group, the emulsion formulations of the Kappaphycus alvarezii extract comprising 3% are applied to subject
Entire facial area skin (2 times a day).Use Laser Scanning Confocal Microscope (Vivascope 1500Trilaser-
Mavig GmbH) and 3D scanner (Fringe projection, Eotech, France;With Optocat software analyze) to
The skin surface situation that experiment starts the measurement of the same day (the 0th day) and the 42nd day is compared (Fig. 4 and Fig. 5).In this respect, aging
Stage 1 indicates the state of most aging, and the stage 4 refers to the least young skin of senescence progress.
As a result, test group showed improved skin aging journey relative to the 0th day at the 42nd day compared with placebo
Degree, as shown in Figure 4.58% subject shows the improvement in their skin stages, and 46% subject's table in test group
Reveal the improvement from ageing phase 1 or 2 to the stage 3 or 4.
Fig. 5 shows the measured value of wrinkle depth in ocular, shows to change at the 42nd day relative to the 0th day wrinkle depth
It has been apt to 27.9%.
It is surveyed in the perception for measuring the average age of above-mentioned subject based on the photo that they shoot before and after the experiment
In examination, the average age of placebo is 62 years old, does not have difference before and after photo.In contrast, test group subject
It is considered occurring younger 3 to 6 years old average.88% subject is considered seeming younger (Fig. 6) in test group.
Reference implementation example 2: adjoint treatment is carried out with telomerase activating composition and ultrasonic laser
(1) telomerase activating composition is prepared
Telomerase activating is prepared using the Kappaphycus alvarezii extract obtained in reference implementation example 1 to combine
Object.Specifically, by the telomerase activating group comprising the Kappaphycus alvarezii extract prepared in reference implementation example 1
Close creme and ampoule that object is configured to the composition for having as follows.
The composition of 1 telomerase activating creme of table
Ingredient | Content % (w/w) |
Glycerol | 8.0 |
Sunflower oil | 3.2 |
Stearic acid | 2.5 |
Mango seed butter | 1.5 |
Kappaphycus alvarezii extract | 0.0056 |
Yeast/fermentation Herba Visci extract | 0.007 |
Lactic acid bacteria/fermentation extract of soybean | 0.0036 |
Yeast/fermentation cogongrass rhizome extractive | 0.0026 |
Purified water | In right amount |
The composition of 2 telomerase activating ampoule of table
Ingredient | Content % (w/w) |
Glycerol | 22.0 |
Pyrrolidone sodium carboxylate | 12.0 |
Xanthan gum | 0.2 |
Citric acid | 0.15 |
Kappaphycus alvarezii extract | 0.0056 |
Yeast/fermentation Herba Visci extract | 0.007 |
Lactic acid bacteria/fermentation extract of soybean | 0.0036 |
Yeast/fermentation cogongrass rhizome extractive | 0.0026 |
Purified water | In right amount |
(2) effect of the adjoint treatment carried out with telomerase activating composition and ultrasonic laser
By above-mentioned telomerase activating composition be applied in the form of topical formulations 24 test groups in reference implementation example 1 by
After the skin of examination person, the ultrasonic laser that irradiation frequency is 10 to 90Hz is to promote for composition to be transferred in skin.
It specifically, will frequency after the above-mentioned telomerase activating composition of 10cc is applied to skin in the form of topical formulations
Rate is set as laser (the Legato-Alma Lasers, Israel of 30Hz;And Sonopact-Medius, South Korea) to entire
Facial area irradiates 10 minutes 1 to 2 time.
In this study, ultrasonic laser i) has dither effect (hammering-shock effect to the skin area through treating;
Push-pull effect) and ii) cause the fuel factor as caused by the vibration in epidermal tissue and corium.In addition, its iii) it destroys by surpassing
The keratinocyte for the degeneration that sound application generates, and effectively transmitted composition by promoting composition to penetrate into space between cells
To corium.
Reference implementation example 3: laser illumination corium and collagen generate effect of stimulation
In this experiment, after treating described in reference implementation example 2, the laser illumination of corium is up to entirely
Facial area and chin area.In this step, the glue in corium is stimulated using the laser for transferring its energy to deep dermis
It is primary at.
In this reference implementation example, the laser illumination of corium is carried out using three kinds of lasers.Firstly, being by wavelength
Laser (GentleMax-Candela, the U.S.) irradiation that 1064nm and frequency are 5Hz 5 minutes on a skin surface, so that swashing
Light energy is goed deep into corium with transferring heat energy.
Next, using high intensity focused ultrasound (HIFU) by frequency be 30 to 50Hz laser (Indigo-K1MED,
South Korea) laser energy (65 DEG C of thermal energy) is transferred to deep dermis and SMAS.The laser has Mode A and Mode B, and
Treatment is formed by respectively irradiating 20 minutes under Mode A and Mode B.This causes the contraction of muscle layer under corium, causes to reduce wrinkle
It is generated with stimulation collagen and elastin laminin.Meanwhile if 10 to 20mm depth there are excess fat layer, this swashs
Light irradiates induced lipolysis and decomposes.
Finally, with the RF laser (40.68MHz of monopolar mode irradiation 92W;Tenor Laser-Alma laser, with color
Column) 6 minutes.This allows RF wave to penetrate dermis of skin/fat deposit and generates heat in deep dermis, and induced tissue is shunk and recombination.
As laser generates heat in connective tissue, blood flow and circulation increase, cause tissue compact and improve dermatoglyph.This
Outside, iuntercellular water and noxious material is discharged, contoured skin in irradiation area is caused significantly to be thinned.
About experimental result, significantly reducing for wrinkle of skin can see immediately after laser illumination, and under double
Bar and cheek region in skin elasticity enhancing, in face contour generate significant difference (Fig. 7).
Reference implementation example 4: the composition and its lipolysis effect for local fat removal comprising hyaluronidase
In this study, it is given to 40 (20 males and 20 women) volunteers and is used for office comprising hyaluronidase
The composition of portion's fat removal, the volunteer had BMI selected from 20 years old or more in adult be 25 or higher abdominal obesity
Patient, give the form of their abdomen area injection.It measures and according to the present invention is gone for local fat as described below
The effect of the composition removed.
(1) injectable composition for local fat removal of the preparation comprising hyaluronidase
About hyaluronidase, using the Liporase Inj. of Daehan New Pharm Co., Ltd, (1500IU/ is small
Bottle, contain 13.3mg lactose hydrous), the amount wherein listed in following table add lidocaine (Hanmi Pharm.Co.,
Ltd.), Pi Lamin (Peniramin, Yuhan Co.), L-carnitine (Dream Pharma) and vitamin-C (Daewoo
Pharm Co., Ltd.) and be sufficiently mixed to prepare the injection solution composition of 100cc.
Ingredient of the table 3 for the composition of local fat removal
(2) the lipolysis effect for the composition of local fat removal
Compare the composition by giving the EXPERIMENTAL EXAMPLE 4 in upper table 3, by give the composition of embodiment 1 to 3 with
And changed by the waistline of endocrinology, conventional edema therapeutic induction.In abdomen area between rib cage and pubis, 50
A point injects the composition of each 1cc, and 50 points are arranged in a manner of 1cm apart respective since navel.Above-mentioned note is repeated weekly
It penetrates, continues surrounding, move injection point every time.1 week measurement waistline is reduced after completing above-mentioned treatment, and 1 upon completion of the treatment
The moon measures waistline again.Record the average value of measured value.
For oedema existing conventional therapy endocrine therapy carry out surrounding, 30 times weekly, behind one week and one month
The reduction of waistline is measured, and the results are shown in table 4.
Table 4
For statistical analysis, the distribution of measured value is obtained using statistics packet SPSS, and is assessed using paired t-test
The influence that test injection reduces waistline.The analysis uses 95% confidence interval, is adjusted according to changes of weight.
In the studies above, using body fat analyzer Inbody body fat analysis shows average fat loss for 1.5 to
2kg。
According to table 4, observe -0.2 ± 1.2cm's of waistline in the comparative example 3 for being wherein given only saline solution
Variation.However, in EXPERIMENTAL EXAMPLE 4, the difference of -9.4 ± 0.2cm for observing waistline for one week after four treatments, and
And four times treatment after one month when difference remain -9.5 ± 0.4cm, show no yo yo effect.
On the other hand, in the comparative example 1 for the hyaluronidase for giving 250IU, [every wheel is treated to 50 points in total
Give 12500IU;4 wheel treatment in total], the difference for treating latter week is -1.6 ± 0.6cm, and treats the difference of the latter moon
For -1.2 ± 0.3cm, show worse effect more significant than the present invention.In the comparative example 2 for the hyaluronidase for giving 650IU
In, [every wheel treatment gives 32500IU to 50 points in total;4 wheel treatment in total], due to recess and bruise after first time treats
Interrupt treatment.
In the case where the endocrinology as edema therapeutic, the waistline as caused by removal oedema reduce it is not significant and
It disappears after one month, clearly illustrates that the waistline obtained by using hyaluronidase reduces the result for being not only oedema removal
It is the result of lipolysis.
As can be seen from the above results, it has proved that injectable composition of the invention has excellent in terms of local fat removal
Different effect and the side effect substantially reduced and no yo yo effect.
In addition, compared with the high dose hyaluronidase injection composition of prior art KR10-2009-0111916A, to the greatest extent
Pipe uses the hyaluronidase of relatively low-dose, but injectable composition of the invention is also shown with the side effect and improvement minimized
Local fat removal effect.
(3) side effect of the composition for local fat removal is given in assessment
The injectable composition of EXPERIMENTAL EXAMPLE 1 to 4 and the injectable composition such as part above (2) of comparative example 1 to 3
In give like that, and the side effect observed in patients is listed in Table 5 below.
Table 5
* skin elasticity is determined using the tactile assessment of 5 subscales: 1: it is excessively poor, 2: it is poor, 3: it is general, 4: it is good, 5: very
It is good.
As shown in table 5, local anesthetic or antihistaminic combination are free of using EXPERIMENTAL EXAMPLE 1 according to the present invention
Object, compared with the high dose composition of comparative example 2, the significant side effect for reducing such as bruise or recess, but observe
To pain and allergic reaction.In addition, containing local anesthetic and antihistaminic compared with EXPERIMENTAL EXAMPLE 1 or comparative example 2
The composition of EXPERIMENTAL EXAMPLE 2,3,4 show with significantly reduced anaphylaxis rubescent, swelling, scabies itching and pain.These
Effect be considered as using the hyaluronidase of local anesthetic and antihistaminic and low dosage caused by.In addition, in reality
In the case where testing embodiment 4, observe excellent skin elasticity, show potential skin elasticity improvement, this facilitate with
The combination of other anti-aging treatments.
In addition, some patients generate slightly recessed due to the fat removal of lipolysis stimulant in EXPERIMENTAL EXAMPLE 3
It falls into and relaxes, be limited to high obesity patient and restore in a short time.
In EXPERIMENTAL EXAMPLE 4, generating stimulant comprising collagen allows the fast quick-recovery of skin elasticity, without being recessed
Or relaxation.
Reference implementation example 5: skin muscular sarcocyte irradiates laser and its elastic reinforcing effect
In this experiment, 9 volunteers in the participant of the treatment for the step of having received reference implementation example 3 are subjected to swash
The treatment of light device.In this step, when laser delivers power to muscle layer, improve in collagen generation, wrinkle and elasticity increases
Strong aspect has the effect of fabulous.In particular, by the way that effectively energy can be passed towards face irradiation laser beam inside mouth
It is handed to skin muscular sarcocyte.
It specifically, the use of wavelength is 2940nm and laser (Fotona Laser- that setpoint frequency is 3Hz
Slovenia it) is irradiated entire facial area 5 minutes from oral mucosa towards face.The laser treatment is painless, and
Fuel factor is provided to oral mucosa with non-ablative, non-invasive manner in the case where without anesthesia, to provide remodeling and tightening effect
Fruit.By transmitting the energy that well controls to make the temperature for being 45 to 65 DEG C in dermis reach, in the mouth of the step
Treatment may cause 30% instantaneous contraction of tissue.Pull to the moment contract of dermis tissue deeper below
Layer generates and promotes effect.
Since above-mentioned laser treatment transmits energy by oral mucosa, it can protect epidermis and stimulate collagen weight
Modeling and virgin rubber original shape are at (lasting up to 6 months).In addition, this laser treatment this have the advantage that, in addition in oral mucosa
Some warming senses except be not accompanied by bleeding or pain, and since oral mucosa especially restores fastly, so without downtime.
In this experiment, 9 volunteers are carried out laser treatment 5 times, is divided into 1 month.As a result, all volunteers
Perioral aging lines substantially reduce.Specifically, although the wrinkle scoring before MFWS (improvement Fitzpatrick wrinkle scale) treatment is
2.22, but the scoring after MFWS treatment is 0.69, shows that wrinkle index reduces about 69%.
It was furthermore observed that instantaneous performance goes out the effect of this step.It is only once treated using the frequency of 1.8Hz, it can be with
That sees nasolabial groove wrinkle substantially reduces (Fig. 8).
Observe using above with reference to the A in embodiment) telomerase activating composition, B) dermis of skin irradiation laser,
C) for local fat removal composition and D) skin muscular sarcocyte irradiation laser therapeutic effect conceive the present invention.Now
Following embodiment the present invention is described in detail will be referred to.However, these embodiments are merely to illustrate the present invention, and should not be construed as with
Any mode limits the present invention.
<embodiment>
The present inventor is determined by experiment compared with the effect observed in the single step in above-mentioned reference implementation example,
When with A) telomerase activating composition, B) dermis of skin irradiates laser, C) composition and D for local fat removal) skin
Skin muscle layer shows synergy when irradiating laser combined treatment, completes the present invention.In order to study according to this hair comprehensively
The effect of the bright external member and cosmetic system for preventing or treating skin aging is used to prevent skin with based on according to the present invention
The external member of skin aging and component-A of cosmetic system) telomerase activating composition, B) dermis of skin irradiation laser, C)
For local fat removal composition and D) skin muscular sarcocyte irradiation laser various combination treat 90 subjects;And
And determine collagen generation/contraction/remodeling effect;Elastic improvement;Effect improving wrinkles;Local fat removal and facial maintenance
Effect;Telomerase activating effect;Colour of skin improvement;Satisfaction and side effect.The datail description of the research is as follows.
(1) subject selects
This research is in October, 2016 to November for preventing the external member of skin aging and the effect of system
90 40 to 50 years old male and female outpatient patients for having visited the clinic (South Korea Seoul) of Sonyouna doctor carry out
's.
The subject for including in this research is that those i) are apprised of purpose and research overview, research process and scheme require simultaneously
Endorsed informed consent form, ii) health, with can be in the research phase including dermopathic acute or chronic disease and iii)
Between carry out follow-up subject.
If subject belongs to any group of in the following group, these subjects are excluded:
1) pregnant woman or breast feeding women and Women of Childbearing Age,
2) dermopathic people is being treated using the topical formulations containing steroids,
3) there is sensitive or allergic skin people,
4) people with cutaneous lesions such as mole, acne, erythema, telangiectasis etc..
5) functional cosmetic product has been used to be used for the people that wrinkle improves in 3 months before the study began,
6) receive the people of the treatment to survey region in 6 months before the study began,
7) internal disease such as hypertension, diabetes, the people of Drugs Treatment on Thyroid Disease and with cancer are being taken or
Disease or other infection diseases;Blood has related disorders;Or the people of autoimmune disease.
(2) method
Subject is grouped at random and with the component (A), (B), (C) and (D) of external member and cosmetic system of the invention no
It is treated with combination.
(A) it applies telomerase activating composition: applying the Kappaphycus containing 0.00056% (w/w) of 3cc
The telomerase activating composition of alvarezii extract, it is then a kind of by super with Legato (Alma laser, Israel)-
Acoustic vibration promotes the ultrasonic laser of cosmetics penetrated deep into whole with 50% irradiation of the frequency of 30Hz and maximum power output
A facial area 10 minutes 1 to 2 time.
(B) irradiate laser illumination with dermis of skin: irradiation frequency is 3 points of 5Hz or lower laser (GentleMax)
Clock, and the indigo laser that A and Mode B irradiation frequency are 30 to 50Hz in mode continues 10 minutes respectively, then with monopole
Mode was with RF Tenor laser illumination 10 minutes of 92W.
(C) composition for local fat removal of the injection comprising hyaluronidase: preparation and above-mentioned reference implementation example 4
The hyaluronidase comprising 30,000IU of the identical 100cc of EXPERIMENTAL EXAMPLE 4, the lidocaine of 210mg, 12mg skin draw
The ascorbic composition for local fat removal of quick, 660mg L-carnitine and 600mg, and at 10 points
The respectively 1cc volume of hyaluronidase of the injection comprising 300IU, between injection point between be divided into 1cm.
(D) skin muscular sarcocyte irradiates laser inside mouth towards the irradiation of face: irradiating integumentary musculature with the frequency of 3Hz
The Fotona laser of layer is inside mouth towards face irradiation 6 minutes.
Primary following treatment carried out to each subject group, each subject group by 10 subject groups at.
Table 6 is used for the treatment of subject group
Treatment | |
Control 1 | A |
Control 2 | B |
Control 3 | C |
Control 4 | D |
Control 5 | A+B+C |
Control 6 | A+B+D |
Control 7 | A+B+C |
Control 8 | B+C+D |
Test group | A+B+C+D |
Determined at any time collagen generation/contraction/remodeling effect, skin elasticity reinforcing effect, effect improving wrinkles, by office
Portion's fat removes caused facial maintenance effect, local fat removal/reduction of lipolysis/oedema, skin in fat cell
Telomerase activating and colour of skin improvement in skin cell.
Embodiment 1: measurement collagen generation/contraction/remodeling effect
The skin biopsy sample of collection research subject is to measure the quantity of collagenous fibres.Specifically, by skin biopsy mark
Originally it is fixed in 2.5% glutaraldehyde solution, is washed with 0.1M phosphate buffer (pH 7.4), and molten in 1% osmium tetroxide
2 hours are fixed after in liquid.Next, 50% ethyl alcohol of skin histology gradient to dehydrated alcohol is dehydrated, propylene oxide is used
Infiltration, is then embedded in Epon resin compound.The thin measurement that cutting thickness is 1 μm is sliced to select interested region,
Then it obtains ultra-thin section and is handled with tannic acid to enhance the resolution ratio of collagenous fibres, then use uranyl acetate and citric acid
Lead carries out conventional dual dyeing.Then it using transmission electron microscope (JEOL 200CX, Japan) observation sample, is put with identical
Big rate (X 40,000) shoots all images to compare the variation of collagenous fibres.As a result it is summarised in table 7 and in Fig. 9 using figure
It represents.
The increase of 7 collagenous fibres par of table
As shown in table 7 and Fig. 9, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 weeks after the treatment
It shows collagenous fibres more better than all control groups and increases effect.Particularly, with the single treatment group treated with A, B, C or D
In collagenous fibres increase the summation of effect compared to (4 weeks after treatment: fiber number increase by 58.5%), test group shows excellent
Synergy (4 weeks after treatment: 127.0%).Moreover, test group show than with combination ABC treatment group and with D treatment
The effect found in single therapy group summation (4 weeks after treatment: 61.4%), with combination ABD treatment group and with C treat list
The summation of the effect found in one treatment group is (4 weeks after treatment: 61.4%), with the group of combination ACD treatment and with B treating single
The summation of the effect found in treatment group is (4 weeks after treatment: 65.6%) and with the group of combination BCD treatment and with A treating single
The summation of the effect found in treatment group is (4 weeks after treatment: 57.5%) better effect.Therefore, by combine all treatment A,
B, C and D, beauty external member of the invention and cosmetic system show excellent collaboration effect in the quantitative aspects for increasing collagenous fibres
Fruit.
Embodiment 2: elastic improvement is measured
Measure the skin elasticity of study subject.Specifically, using DermaLab USB elastic probe (Cortex
Technology, Inc.) evaluation studies subject skin elasticity improve.The instruction of DermaLab USB spring probe is due to feeling emerging
Change of skin caused by the suction in interesting region and puff duration and restoring force.Before carrying out the measurements, using special adhesive tape
The probe of device is bonded to the left cheek of test subject.In view of causing skin fatigue degree in same position duplicate measurements
It increases, each elasticity measurement position is using only once.Using the variation of application software (version 1.09) analyzing skin elasticity, this is answered
It is the exclusive analysis program of DermaLab USB with software.In the parameter of measurement, analyzed using Young's modulus (E), poplar
Family name's modulus (E) is bigger, shows that elasticity is higher.Young's modulus (E) is based on when skin surface increases 1.5mm i.e. in measurement probe
The distance between two infrared detection lines when required power difference, and its measurement unit is MegaPascal (MPa).?
Before treatment (baseline) and treatment after 1 week, 2 weeks, 3 weeks and 4 weeks progress elasticity measurement.As a result it is summarised in table 8, and in Figure 10
Make to graphically illustrate.
8 mean skin elasticity of table improves
As shown in table 8 and Figure 10, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
Show skin elasticity improvement more better than all control groups week.Particularly, with the single therapy treated with A, B, C or D
Compared to (4 weeks after treatment: elasticity improves 46.01%), test group shows excellent the summation of the skin elasticity improvement of group
Effect is (4 weeks after treatment: 81.50%).Moreover, test group is shown than the group with combination ABC treatment and single the controlling with D treatment
The summation of the effect found in treatment group is (4 weeks after treatment: group 48.56%), with combination ABD treatment and single controlling with C treatment
The summation of the effect found in treatment group is (4 weeks after treatment: group 36.35%), with combination ACD treatment and single controlling with B treatment
The summation of the effect found in treatment group is (4 weeks after treatment: 47.25%) and with the group of combination BCD treatment and with A treating single
The summation of the effect found in treatment group is (4 weeks after treatment: 47.82%) better effect.Hereby it has been demonstrated, that passing through treatment
A, the organic assembling of B, C and D, of the invention external member and cosmetic system for preventing skin aging is in terms of skin elasticity improvement
Show excellent synergy.
Embodiment 3: assessment effect improving wrinkles
Measure the effect improving wrinkles of study subject.For the qualitative assessment to corrugate, corrugated degree using quantization
Device (Aramo TS, by Aram HUVIS Co., South Korea program).The Silver Mirror (x10 mirror) for being 30mm by diameter
Head and the skin surface of area-of-interest be in close contact, and be depressed on skin using constant pressure perpendicular.Then, it uses
The difference for the skin brightness that light from device head generates quantifies corrugation.The negativity model of thus obtained wrinkle of skin can
To use software to convert the format that is positive, or different measurement line adjusting parameter values can be directed to.As for corrugation degree, 10~12
Value indicate twenties people normal corrugation.As a result it is summarised in table 9, and makes to graphically illustrate in Figure 11.
Table 9 averagely wrinkles
As shown in table 9 and Figure 11, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
Show effect improving wrinkles more better than all control groups week.Particularly, with the single treatment group treated with A, B, C or D
The summation (4 weeks after treatment: wrinkle reduces -3.60) of effect improving wrinkles is compared, and test group shows excellent synergy and (controls
4 weeks after treatment: -6.81).Moreover, test group is shown than sending out with the group of combination ABC treatment and in the single therapy group of D treatment
The summation of existing effect is (4 weeks after treatment: -3.67), with the group of combination ABD treatment and in the single therapy group of C treatment finding
Effect summation (after treatment 4 weeks: -2.94), with the group of combination ACD treatment and in the single therapy group of B treatment finding
The summation of effect is (after treatment 4 weeks: -3.90) and with the group of combination BCD treatment and in the single therapy group of A treatment finding
The summation of effect is (4 weeks after treatment: -2.74) better effect.Therefore, of the invention by combining all treatment A, B, C and D
External member and cosmetic system for preventing skin aging have excellent synergy in terms of wrinkle improvement.
Embodiment 4: assessment is by local fat removal and decrease in edema bring skin repair effect
Measure the skin repair effect by applying the composition generation for local fat removal etc. of study subject.Tool
Body, use the thickness of the subcutaneous fat of the facial area of ultrasonic measurement study subject.Using French sound section image (English:
SuperSonic Imagine, Les Jardins de la Duranne, Aix en Provence, France) device progress
Measurement based on ultrasound.Tester and subject, which face each other, to be seated to measure the subcutaneous fat in cheek and chin area
Thickness, and make the minimum pressure on Vltrasonic device correctly to measure thickness.By aqueous gel be applied to measurement site with
Ultrasound is transmitted in help, and is measured at two positions using the high frequency linearity probe of 6.0MHz, and average value is then calculated.Knot
Fruit is summarised in table 10, and makes to graphically illustrate in Figure 12.
The variation of fat thickness in 10 chin area of table
As shown in table 10 and Figure 12, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
It shows excellent fat thickness week and reduces effect.As can be seen that the effect is depended on comprising using C (to go for local fat
The composition removed)-element of the invention treatment, and after the treatment 1 week it can be observed that significant synergy, holds
Continue after treatment 4 weeks.
Embodiment 5: measurement telomerase activating effect
The telomerase activating degree of evaluation studies subject.Study subject is forbidden to use for 24 hours before its blood testing
Caffeine, excess drug or metabolism regulators, and in 10 points of extraction blood samples of the morning after they sufficiently rest.Using sandwich
The amount of enzyme immunoassay measurement sample telomerase.Specifically, the standard containing Telomerase or test sample are applied to painting
There is the plate to Telomerase (TA) monoclonal antibody (MAb) with specificity, so that Telomerase is attached on plate.In order to quantify sample
The amount of this telomerase, preparation are specifically bound to the polyclonal antibody of HRP (horseradish peroxidase) conjugation of Telomerase simultaneously
It is applied to plate, causes its Telomerase relevant to plate in conjunction with sandwich.When all reactions are completed after incubation, wash off
Remaining unreacted excess material on plate, and react substrate solution to determine the amount of the HRP combined.When substrate is anti-with HRP
At once, it is hydrolyzed by the peroxidase activity of HRP, leads to showing for substrate solution color.By addition sulfuric acid terminate enzyme with
This reaction between substrate, and color substrate solution is measured under the wavelength of 450nm with spectrophotometer, to obtain standard song
Line is to calculate the concentration of Telomerase.As a result it is summarised in table 11, and makes to graphically illustrate in Figure 13.
11 telomerase activation of table improves
As shown in table 11 and Figure 13, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
Show Activation of Telomerase effect more better than all control groups week.Particularly, with the single treatment group treated with A, B, C or D
For the summation of telomerase activation effect compared to (4 weeks after treatment: telomerase activation increases by 1.03), test group shows excellent association
Same effect is (4 weeks after treatment: 1.20).Moreover, test group is shown than the group with combination ABC treatment and single the controlling with D treatment
The effect found in treatment group summation (4 weeks after treatment: 1.02), with combination ABD treatment group and with C treat single therapy group
The summation of the effect of middle discovery is (4 weeks after treatment: 1.01), with the group of combination ACD treatment and in the single therapy group of B treatment sending out
The summation of existing effect is (4 weeks after treatment: 0.99) and with the group of combination BCD treatment and in the single therapy group of A treatment finding
Effect summation (4 weeks after treatment: 1.01) better synergy.Therefore, by combining all treatment A, B, C and D, this hair
The bright external member for being used to prevent skin aging and cosmetic system have excellent telomerase activating effect.
Embodiment 6: measurement colour of skin improvement
(1) skin hydration is measured
Measure the skin hydration of study subject.This is completed by the capacitor of measurement reflection water content, in skin
Water has highest dielectric constant, is indicated by arbitrary unit (AU).It is transferred to and connects that is, skin hydration usually passes through measurement
The capacitor for touching the weak current of the probe of skin surface determines.Since water content and capacitor are proportional to one another, skin hydration is got over
Greatly, measured value is higher.Therefore, which can be substantially by applied cosmetics or drug (leading in electric scattered field
Body track) influence under conditions of water content under test constantly cuticula in 30~40 μm of depth.In addition, the device has in spy
Under different test condition, for example, assessing the only of skin hydration when probe keeps slight distance with skin and is not directly contacted with skin
Special ability.The range of readings of the device is from minimum 0AU to 120AU.In this respect, the capacitor of solid is usually 7F (farad), and
The capacitor of water is 81F.Then, if the weak current of 7F to 81F flows, capacitance difference will occur.120 are divided that difference by, is obtained
The value of above-mentioned arbitrary unit (AU).According to the principle, when being measured by the device, the plastics for being typically free of any water are shown
Capacitor with about 6~8AU, and 100% moisture will provide 120AU when measuring.That is, higher value is explained
To indicate higher water content.When by diameter be 16mm probe be placed on skin surface be in close contact measuring point and with
When constant pressure is vertically pressed on the skin, there is digital reading, and use the average value for carrying out 5 measurements within a certain area
(middle section between cheekbone and chin, 4 × 4cm) is recorded.Reading indicates that hydration levels are good for 35~40,31~34
It indicates slightly to lack moisture, and 25~30 indicate exsiccosis.As a result it is summarised in table 12, and makes to figure in Figure 14
Out.
12 skin hydration of table improves
As shown in table 12 and Figure 14, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
Show skin hydration improvement more better than all control groups week.Particularly, with the single therapy treated with A, B, C or D
The summation (4 weeks after treatment: skin hydration increases by 2.27) of skin hydration improvement in group is compared, and test group shows excellent
Synergy (4 weeks after treatment: 7.39).Moreover, test group is shown than the group treated with combination ABC and the list treated with D
The summation of the effect found in one treatment group is (4 weeks after treatment: group 2.71), with combination ABD treatment and single controlling with C treatment
The effect found in treatment group summation (4 weeks after treatment: 3.56), with combination ACD treatment group and with B treat single therapy group
The summation of the effect of middle discovery is (4 weeks after treatment: 2.32) and in the group of combination BCD treatment and the single therapy group with A treatment
It was found that effect summation (4 weeks after treatment: 2.61) better synergy.Therefore, by combining all treatment A, B, C and D,
The external member for being used to prevent skin aging of the invention and cosmetic system have excellent skin hydration improvement.
(2) measurement of skin roughness
For the skin roughness of evaluation studies subject, using the image of optical principle shooting test zone, and by skin
Skin surface profile is converted into chart and number.The Silver Mirror (× 60 mirror) for the use of diameter being thus 30mm, and by the head of the device
Portion is placed on the measuring point being in close contact with skin surface, and is vertically pressed on the skin using constant pressure, and use exists
The average value of 5 measurements carried out in certain region (middle section between cheekbone and chin, 4 × 4cm) is recorded.Reading is
28~31 indicate that roughness is good, and 32~35 indicate that skin is slightly coarse, and 36~40 indicate pachylosis.As a result it is summarised in table
In 13, and make to graphically illustrate in Figure 15.
13 skin roughness of table
As shown in table 13 and Figure 15, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
Show skin roughness reducing effect more better than all control groups week.Particularly, it is individually controlled with what is treated with A, B, C or D
The summation (4 weeks after treatment: skin roughness reduces -2.17) of skin roughness reducing effect in treatment group is compared, test group table
Reveal excellent synergy (4 weeks after treatment: -3.82).Moreover, test group shows the group than being treated with combination ABC and uses D
The summation of the effect found in the single therapy group for the treatment of is (4 weeks after treatment: -2.55), with the group of combination ABD treatment and with C controlling
The summation of the effect found in the single therapy group for the treatment of is (4 weeks after treatment: -2.21), with the group of combination ACD treatment and with B treating
Single therapy group in the summation of effect that finds (4 weeks after treatment: being treated -1.75) and with the group of combination BCD treatment and with A
Single therapy group in the summation of effect that finds (4 weeks after treatment: -3.56) better synergy.Therefore, by combining institute
There are treatment A, B, C and D, there is excellent skin roughness to drop for the external member for being used to prevent skin aging of the invention and cosmetic system
Low synergy.
(3) measurement of pigmentation and pore
Use RSA (Robo Skin Analyzer CS 50, In Forward.Inc., Japan) measuring study subject
Pigmentation amount variation.RSA is the instrument for allowing to carry out pore, pigmentation, wrinkle, colour of skin etc. joint inspection.Its
Can be by using the illumination of compact molding box and from identical angle shot photo, and there is high reproducibility.With the apparatus measures
The pore of study subject and the variation of pigmentation amount, by image capture apparatus and image analysis computer system two parts group
At instrument capture wrinkle, pigment, the colour of skin, the image information of pore etc., and directly generate result.Because it can be from three
Different angle shot photos, therefore it to can be carried out accurate analysis.As a result it is summarised in table 14, and used in Figure 16
Chart is shown.
14 pigmentation of table reduces (%)
As shown in table 14 and Figure 16, test group (with combination A, B, C and D treatment) according to the present invention 1 week to 4 after the treatment
It shows pigmentation more better than all control groups week and reduces effect.Test group show than with combination ABC treatment group and
With D treatment single therapy group in find effect summation (4 weeks after treatment: -3.39), with combination ABD treat group and use C
The summation of the effect found in the single therapy group for the treatment of is (4 weeks after treatment: -3.83), with the group of combination ACD treatment and with B controlling
The summation of the effect found in the single therapy group for the treatment of is (4 weeks after treatment: -3.38) and with the group of combination BCD treatment and with A controlling
(4 weeks after treatment: -3.26) significantly excellent synergy is (4 after treatment for the summation of the effect found in the single therapy group for the treatment of
Week: -4.58).Therefore, by combining all treatment A, B, C and D, the external member and beauty for being used to prevent skin aging of the invention
There is system significantly excellent cutaneous pigmentation to reduce synergy.
Embodiment 7: for change of skin and satisfaction after treating and the evaluation questionnaire of side effect
Evaluation questionnaire investigation is carried out with the satisfaction of study subject about changing after 4 weeks skin treatings after treatment.It asks
Volume is by forming 8 problems of the self-assessment for investigating subject after treatment, 7 problems including assessing change of skin satisfaction
With 1 problem of future usage intention.In addition, the unfavorable dermoreaction in observational study region, such as erythema, oedema, decortication, scabies
Itch and shouting pain, and result is summarised in table 15.
Table 15
It can be noted that the external member or cosmetic system according to the present invention for preventing skin aging (is surveyed such as in table 15
Examination group-is treated with ABCD) highest satisfaction is obtained to all effect item purpose self-assessments.
The collagenous fibres shown in number increase, elasticity changes with embodiment 1 to 6 for the self-assessment of these effectiveness results
Kind, wrinkle improvement, skin repair effect, hydration improvement, roughness improvement are consistent with the result that pigmentation improves, and show basis
Of the invention external member or cosmetic system for preventing skin aging is by the inclusion of component A, B, C and D related to skin aging
Various aspects have synergy.Therefore, it is used to prevent the combination ABCD of skin aging, external member from controlling with according to the present invention
In the group for the treatment of, 80% subject indicates have future strong use to be intended to, and subject's expression in control group less than 30% will
To have using intention.
Meanwhile each from C single therapy group, ABD combined therapy group, ACD combined therapy group and BCD combined therapy group
One subject undergoes erythema, and combines each from C single therapy group, D single therapy group, ABD combined therapy group, ACD
One subject for the treatment of group and BCD combined therapy group undergoes itch.However, being not significantly different between treatment group is to be worth note
Meaning.
Those skilled in the art in the invention will be understood from the foregoing description, and the present invention can not depart from its technology
Implement in other embodiments in the case where design or essential characteristic.In this respect, previous embodiment should be construed as only
It is illustrative and be all non-limiting in any way.Therefore, protection scope of the present invention will by appended claims and
Its equivalent determines.
Claims (23)
1. a kind of for preventing the external member of skin aging comprising
A) telomerase activating composition;
B) dermis of skin irradiates laser;
C) the composition for local fat removal of the hyaluronidase comprising 300IU to 600IU;With
D) skin muscular sarcocyte irradiates laser.
2. external member according to claim 1, wherein prevent skin aging be collagen generation, collagen contraction, collagen remodeling,
Skin repair, skin elasticity enhancing, wrinkle improvement, local fat removal, the lipolysis in fat cell, decrease in edema, skin
Telomerase activating, skin hydration in skin cell improve, in skin roughness improvement, cutaneous pigmentation improvement and colour of skin improvement
It is one or more.
3. external member according to claim 1, wherein A) telomerase activating composition increase Skin Cell in telomere albumen
The expression of the subunit protein of complex, the protein subunits of the telomere protein complexes be selected from TRF1 (telomere repetition factor 1),
TRF2 (telomere repetition factor 2), RAP1 (suppressing Activating protein-1), TIN2 (TERF1- interaction nuclear factor 2), POT1 (telomere
Protected protein 1) and one of TPP1 (three peptidyl peptidases 1) or a variety of.
4. external member according to claim 1, wherein A) telomerase activating composition include Dendropanax
Morbifera Lev. extract, Kappaphycus alvarezii extract or their mixture are as active constituent.
5. external member according to claim 1, wherein A will be applied) telomerase activating composition and frequency of use be 10 to
The ultrasonic laser treatment of 90Hz combines.
6. external member according to claim 1, wherein B) dermis of skin irradiation laser be selected from frequency be 2 to 100Hz
One of laser and RF (radio frequency) laser are a variety of, transfer thermal energy to corium or are transferred to corium and SMAS (shallowly
Table muscular aponeurotic system).
7. external member according to claim 6, wherein B) to be selected from frequency be swashing for 5Hz to dermis of skin irradiation laser
The RF laser that the laser and frequency that light device, frequency are 30 to 50Hz are 35 to 45MHz it is one or more.
8. external member according to claim 1, wherein C) hyaluronidase comprising 300IU to 600IU for local rouge
The composition of fat removal is injectable composition.
9. external member according to claim 8, wherein the injectable composition for local fat removal further includes local anaesthesia
Agent, antihistaminic, lipolysis stimulant and collagen generate one of stimulant or a variety of.
10. external member according to claim 9, wherein the local anesthetic is lidocaine, and the antihistaminic is skin
Stretching-sensitive, the lipolysis stimulant is L-carnitine, and it is vitamin C that the collagen, which generates stimulant,.
11. external member according to claim 10, wherein the injection combination for local fat removal of every single dose volume
Object includes the hyaluronidase of 300IU to 600IU, is counted on the basis of the total weight of injectable composition, the injectable composition is also
The lidocaine for being 0.08 to 0.4% comprising weight percent as local anesthetic, weight percent is 0.01 to 0.02%
Skin stretching-sensitive as antihistaminic, L-carnitine that weight percent is 0.01 to 4.0% as lipolysis stimulant and again
Vitamin C that percentage is 0.1 to 2.0% is measured as collagen generation stimulant, remaining is salting liquid, and the composition with
0.5 to 2cc single dose volume is injected, between injection point between be divided into 0.5 to 1.5cm.
12. external member according to claim 11, wherein for local fat removal injectable composition also with 0.01 to
The total amount of 4.0 weight % includes one kind or more selected from phosphatidyl choline, aminophylline, caffeine, placental hormone and pentoxifylline
Kind component.
13. external member according to claim 1, wherein D) skin muscular sarcocyte irradiation laser inside mouth towards face
Portion's irradiation, and be the laser that frequency is 1 to 3.5Hz, skin muscular sarcocyte is transferred thermal energy to, or be transferred to integumentary musculature
Layer and dermis.
14. external member according to claim 13, wherein irradiation D) skin muscular sarcocyte irradiation laser, so that in target skin
Reach the temperature of 45 to 70 range in skin layers.
15. a kind of for preventing or treating the cosmetic system of skin aging comprising:
A) telomerase activating composition;
B) dermis of skin irradiates laser;
C) the composition for local fat removal of the hyaluronidase comprising 300IU to 600IU;With
D) skin muscular sarcocyte irradiates laser.
16. cosmetic system according to claim 15 further includes ultrasonic laser and A that frequency is 10 to 90Hz)
Telomerase activating composition.
17. cosmetic system according to claim 15, wherein B) dermis of skin irradiation laser be selected from frequency be 2 to
Laser and RF (radio frequency) laser of 100Hz it is one or more, transfer thermal energy to corium or be transferred to corium and
SMAS。
18. cosmetic system according to claim 15, wherein C) for local fat removal composition be injection combination
Object, and the composition for local fat removal also includes local anesthetic, antihistaminic, lipolysis stimulant and collagen
Generate stimulant.
19. cosmetic system according to claim 18, wherein C) note for local fat removal of every single dose volume
The hyaluronidase that composition includes 300IU to 600IU is penetrated, is counted on the basis of the total weight of injectable composition, the injection group
Close object also include weight percent be 0.08 to 0.4% lidocaine as local anesthetic, weight percent be 0.01 to
0.02% skin stretching-sensitive is stimulated as antihistaminic, the L-carnitine that weight percent is 0.01 to 4.0% as lipolysis
The vitamin C that agent and weight percent are 0.1 to 2.0% generates stimulant as collagen, remaining is salting liquid, and described
Composition is injected with 0.5 to 2cc single dose volume, between injection point between be divided into 0.5 to 1.5cm.
20. cosmetic system according to claim 15, wherein D) skin muscular sarcocyte irradiation laser inside mouth towards face
Portion's irradiation, and be the laser that frequency is 1 to 3.5Hz, it transfers thermal energy to skin muscular sarcocyte or is transferred to integumentary musculature
Layer and dermis.
21. a kind of for preventing the beauty method of skin aging, wherein following steps progress is considered that its is suitable at least once and not
Sequence:
I) the step of applying telomerase activating composition;
Ii the step of) irradiation dermis of skin irradiates laser 3 to 60 minutes;
Iii) part is used for inject with the interval between 0.5 to 1.5cm injection point and with 0.5 to 2cc single dose volume
The step of composition of fat removal;With
Iv the step of) being irradiated laser 3 to 10 minutes inside mouth towards face irradiation skin muscular sarcocyte.
22. beauty method according to claim 21, further include with step i) simultaneously or after step i) immediately according to
Radio frequency rate is ultrasonic laser 5 to 20 minutes of 10 to 90Hz.
23. beauty method according to claim 21, wherein step ii) in dermis of skin irradiation laser be selected from frequency
Laser, the laser that frequency is 30 to 50Hz and the RF laser that rate is 5Hz it is one or more, wherein
The frequency is laser illumination 3 to 8 minutes of 5Hz,
The frequency is laser illumination 15 to 40 minutes of 30 to 50Hz, also,
The RF laser is irradiated 4 to 10 minutes with the frequency of 40.68MHz.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170012122 | 2017-01-25 | ||
KR10-2017-0012122 | 2017-01-25 | ||
KR1020170091989A KR102048119B1 (en) | 2017-01-25 | 2017-07-20 | Kit for prevention of skin aging and a system for skin beauty |
KR10-2017-0091989 | 2017-07-20 | ||
PCT/KR2018/001019 WO2018139835A1 (en) | 2017-01-25 | 2018-01-23 | Kit and aesthetic system for prevention of skin aging |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110177541A true CN110177541A (en) | 2019-08-27 |
Family
ID=63251633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880005071.7A Pending CN110177541A (en) | 2017-01-25 | 2018-01-23 | For preventing the external member and cosmetic system of skin aging |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102048119B1 (en) |
CN (1) | CN110177541A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110751666A (en) * | 2019-11-30 | 2020-02-04 | 上海澄镜科技有限公司 | System device equipped on intelligent beauty mirror for skin detection and modeling |
TWI829369B (en) * | 2021-09-29 | 2024-01-11 | 日商西尾股份有限公司 | beauty method |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102201133B1 (en) * | 2020-01-31 | 2021-01-11 | 진로사 | Composition for anti-aging and removing localized fat |
KR102195330B1 (en) * | 2020-08-26 | 2020-12-28 | 공주명 | Injection composition for local fat reduction |
KR102438731B1 (en) * | 2020-11-30 | 2022-09-01 | 한국과학기술연구원 | A composition for inhibiting skin senescence comprising extract from fenugreek sprout |
KR102647782B1 (en) * | 2023-12-01 | 2024-03-18 | 고려대학교 산학협력단 | An injectable composition for enhancing decomposition and metabolism of localized fat |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1578688A (en) * | 2001-06-29 | 2005-02-09 | 光生物科学有限公司 | Method and apparatus for the photomodulation of living cells |
US20090214607A1 (en) * | 2005-05-13 | 2009-08-27 | Sederma | Topical use of teprenone |
CN103702659A (en) * | 2011-06-03 | 2014-04-02 | 阿勒根公司 | Dermal filler compositions including antioxidants |
US20160016015A1 (en) * | 2004-09-24 | 2016-01-21 | Guided Therapy Systems, Llc | Systems and methods for improving an outside appearance of skin using ultrasound as an energy source |
US20160339042A1 (en) * | 2014-11-21 | 2016-11-24 | Lipodissolve Therapeutics Inc. | Topical lipolysis compositions and methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130077509A (en) * | 2011-12-29 | 2013-07-09 | 경희대학교 산학협력단 | Method and clinical protocol for removing wrinkles using high radio-frequency |
FR2987998B1 (en) | 2012-03-19 | 2014-04-25 | Isp Investments Inc | COSMETIC COMPOSITION COMPRISING A SYNERGISTIC ACTION TRF2 PROTEIN ACTIVATION SYSTEM COMPRISING AN ASSOCIATION OF PEPTIDE EXTRACT OF SOY AND YEAST AND USES THEREOF |
-
2017
- 2017-07-20 KR KR1020170091989A patent/KR102048119B1/en active IP Right Grant
-
2018
- 2018-01-23 CN CN201880005071.7A patent/CN110177541A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1578688A (en) * | 2001-06-29 | 2005-02-09 | 光生物科学有限公司 | Method and apparatus for the photomodulation of living cells |
US20160016015A1 (en) * | 2004-09-24 | 2016-01-21 | Guided Therapy Systems, Llc | Systems and methods for improving an outside appearance of skin using ultrasound as an energy source |
US20090214607A1 (en) * | 2005-05-13 | 2009-08-27 | Sederma | Topical use of teprenone |
CN103702659A (en) * | 2011-06-03 | 2014-04-02 | 阿勒根公司 | Dermal filler compositions including antioxidants |
US20160339042A1 (en) * | 2014-11-21 | 2016-11-24 | Lipodissolve Therapeutics Inc. | Topical lipolysis compositions and methods |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110751666A (en) * | 2019-11-30 | 2020-02-04 | 上海澄镜科技有限公司 | System device equipped on intelligent beauty mirror for skin detection and modeling |
TWI829369B (en) * | 2021-09-29 | 2024-01-11 | 日商西尾股份有限公司 | beauty method |
Also Published As
Publication number | Publication date |
---|---|
KR102048119B1 (en) | 2019-11-22 |
KR20180087815A (en) | 2018-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110177541A (en) | For preventing the external member and cosmetic system of skin aging | |
Hague et al. | Therapeutic targets in the management of striae distensae: A systematic review | |
Shaffer et al. | Keloidal scars: a review with a critical look at therapeutic options | |
Avcil et al. | Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study | |
Wollina et al. | Esthetic and cosmetic dermatology | |
US20110251523A1 (en) | Skin care apparatus and method of skin care using the same | |
LERNER et al. | Vitiligo and sympathectomy: the effect of sympathectomy and a-melanocyte stimulating hormone | |
Tanaka et al. | Treatment of skin laxity using multisource, phase-controlled radiofrequency in Asians: visualized 3-dimensional skin tightening results and increase in elastin density shown through histologic investigation | |
Tansathien et al. | Development of sponge microspicule cream as a transdermal delivery system for protein and growth factors from deer antler velvet extract | |
RU2491022C1 (en) | Method of correcting dehydrated involutionally changed face skin in women | |
Erkiert‐Polguj et al. | The evaluation of elasticity after nonablative radiofrequency rejuvenation | |
Lee et al. | Rejuvenation of photoaged aged mouse skin using high-intensity focused ultrasound | |
US20180207087A1 (en) | Kit and aesthetic system for prevention of skin aging | |
Farouk et al. | Split body comparative clinical and radiological study of fractional CO2 laser versus carboxytherapy in treatment of striae distensae | |
Li et al. | Early intervention by Z-plasty combined with fractional CO2 laser therapy as a potential treatment for hypertrophic burn scars | |
Maia et al. | Comparative effects of fractional radiofrequency and microneedling on the genitalia of postmenopausal women: Histological and clinical changes | |
Casabona | Microfocused ultrasound with visualization for the treatment of stretch marks | |
Cheng et al. | Synergistic effect of microneedle-delivered extracellular matrix compound and radiofrequency on rejuvenation of periorbital wrinkles | |
Shu et al. | Effectiveness of a radiofrequency device for rejuvenation of aged skin at home: a randomized split-face clinical trial | |
Kim et al. | Clinical utility of the 2-line high-intensity focused ultrasound for skin tightening in Republic of Korea: retrospective clinical study | |
Kislevitz et al. | Bipolar fractional radiofrequency treatment of suprapatellar skin assessment using noninvasive devices and microbiopsy | |
Dana et al. | The peptide argireline-the importance of local application on the skin, in the light of current knowledge | |
Reddy et al. | Mesotherapy in face | |
Khalil et al. | Cellulite: An Update on Pathogenesis and Management | |
KR102562755B1 (en) | Cosmetic composition comprising isoflavone aglycone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190827 |